18
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

New indazole derivatives as phosphodiesterase type 4 inhibitors

Pages 605-608 | Published online: 25 Feb 2005

Bibliography

  • PALYFREYMAN MN: Phosphodiesterase type IV inhibi-tors as anti-inflammatory agents. Drugs of the Future (1995) 20:793–804.
  • RAEBURN D, UNDERWOOD SL, LEWIS SA et al.: Anti-inflammatory and bronchodilator properties of RP73401, a novel and selective phosphodiesterase type IV inhibitor. Brit. J. Pharmacol. (1994) 113:1423–1431.
  • MCGEEHAN GM, BECHERER JD, BAST RC et al: Regula-tion of tumour necrosis factor-a processing by a metal-loproteinase inhibitor. Nature (1994) 370:558–561.
  • LEE JC, LAYDON JT, MCDONNELL PC et al: A protein ki-nase involved in the regulation of inflammatory cyto-kine biosynthesis. Nature (1994) 372:739–746.
  • BEAVO JA, CONTI M, HEASLIP RJ: Multiple cyclic nucleo-tide phosphodiesterases. MM. Pharmacol. (1994) 46:399–405.
  • WILLIAMS RD, FELDMANN M, MAINI RN: Anti-tumor ne-crosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA (1992) 89:9783–9788.
  • ASHTON MJ, COOK DC, FENTON G et al: Selective type IV phosphodiesterase inhibitors as antiasthmatic agents. The syntheses and biological activities of 3-cyclopentoxy-4-methoxy-benzamides and analogues. J. Med. Chem. (1994) 37:1696–1703.
  • •This paper reveals the potent PDE4 inhibitor, RP73401.
  • WARRELLOW GJ: The Design and Synthesis of Novel Triarylethanes as Potent, Selective, Orally Active PDE4 Inhibitors of Asthma. Peptidomimetrics and small mole-cule design. Washington DC, March 6–8 (1996).
  • BARNETT MS, CHRISTENSEN SB, ESSAYAN DM et al.: SB207499 a potent and selective phosphodiesterase (PDE) IV inhibitor, suppresses activities of several and inflammatory cells. Amer. J. Resp. Grit. Care. Med. (1994) 149(Suppl):Abstr. A209.
  • LOMARDO LJ, BAGLI JF, GOLANKIEWICZ JM et al.: Noveloximecarbamates and oxime-carbamates as potent isozyme-selective inhibitors of PDE4. 205th ACS Natl. Meeting (March 28th to April 2nd, Denver). (1993) MEDI–128.
  • LOWE JA, CHENG JB: The PDE4 family of calcium-independent phosphodiesterse enzymes. Drugs of the Future (1992) 17:799–807.
  • SCHMEICHEN HH, SCHNEIDER HH, WACHTEL H: Closecorrelation between behavioural response and bind-ing in vivo for inhibitors of the rolipram-sensitive phosphodiesterase. Psychopharmacology (1990) 103:17–20.
  • WILSON M, SULLIVAN M, BROWN M, HOUSLAY, MD: Pu-rification, characterisation and analysis of rolipram inhibition of a human type IVa cyclic AMP-specific phosphodiesterase expressed in yeast. Biochem. J. (1994) 304:407–415.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.